SAN ANTONIO--(BUSINESS WIRE)--Acelity today announced that it has acquired exclusive worldwide rights from The GID Group, Inc. for the REVOLVE™ System, a fat processing technology used in both reconstructive and cosmetic procedures to facilitate high-volume, autologous fat grafting. LifeCell Corporation, an Acelity Company, has held exclusive rights to distribute the REVOLVE™ System in the US and Canada since 2013. This new agreement provides LifeCell with worldwide rights for development, manufacturing and commercialization of the device.
“We are looking forward to working with the plastic surgery community to further develop the REVOLVE™ System and bring its clinical and economic benefits to patients around the world,” said Ron Silverman, MD, Chief Medical Officer, Acelity. “It aligns with our strategy of broadening our regenerative medicine portfolio of products for plastic surgeons by providing solutions that go beyond acellular dermal matrix procedures.”
Fat grafting is used in a minimally-invasive procedure that removes fat from one part of the body and grafts it to another. The technique is being used more frequently in both reconstructive and cosmetic procedures because it often provides more natural solutions. The REVOLVE™ System is designed to yield rapid, reliable results in high-volume procedures through the use of a simple, closed system that controls critical variables in the procedure.
“Fat grafting use among plastic surgeons is growing, but there remain many opportunities to improve the way it is performed, particularly in large volume breast procedures,” said Adam Katz, MD, Plastic Surgeon and co-founder of The GID Group, Inc. “We believe Acelity is the ideal company to further develop this technology and create new ways to deliver the benefits of fat grafting to patients worldwide.”
About Acelity
Acelity is a global wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. We are committed to advancing the science of healing and restoring people’s lives. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world. We believe in enabling better futures for everyone. Please visit acelity.com.
